Home


News Release Archives:

2005 | 2004 | 2003
2002 | 2001 | 2000
1999 | 1998 | 1997



 

MGH stem cell researcher receives funding from Stowers Medical Institute
Missouri philanthropists support work of Chad Cowan, PhD, investigator with MGH Center for Regenerative Medicine and Harvard Stem Cell Institute

BOSTON - June 23, 2006 - Chad Cowan, PhD, a member of the Center for Regenerative Medicine at Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute, has been named an assistant investigator by the Stowers Medical Institute (SMI) of Cambridge, Mass.

Cowan is the second principal investigator appointed by SMI, a medical research organization founded and funded by Kansas City philanthropists Jim and Virginia Stowers. SMI's support of Cowan's work is similar to the support provided to several MGH researchers by the Howard Hughes Medical Institute. Cowan will remain at MGH but will become an employee of SMI, which will provide more than $4.75 million in funding for Cowan's lab over the next four years.

Cowan has earned widespread recognition for his groundbreaking work using early, or embryonic, stem cells to understand the contributions of environmental and genetic factors to the development of disease.

"I am excited to begin working with the Stowers Medical Institute," said Cowan. "Jim and Virginia Stowers are true champions of biomedical research, and I am honored to receive their support. By combining the resources of SMI, MGH, and the Harvard Stem Cell Institute, my research team can move forward rapidly with some very exciting science."

Jim Stowers explained the decision to fund Cowan's research by saying, "Dr. Cowan is a tremendously talented young scientist. His work in early stem cell research has the potential to shed light on a variety of diseases that have eluded effective treatments or cures. Virginia and I are pleased to support his important research at Massachusetts General Hospital."

"This gift will foster a premier young scientist in a field brimming with potential," says David Scadden, MD, director of the MGH Center for Regenerative Medicine and co-director of the Harvard Stem Cell Institute. "It is through the generosity and vision of the Stowers, MGH and the Innovation Fund that we can accelerate discovery and shape this potential into a reality for patients. Chad is an exceptional addition to a team of talented, dedicated scientists in the Center for Regenerative Medicine and the Harvard Stem Cell Institute, and I am deeply grateful to Jim and Virginia Stowers for enabling him to join us."

Stowers founded the multi-billion-dollar American Century Companies in 1958. Inspired by personal experiences with cancer, he and Mrs. Stowers founded the Stowers Institute for Medical Research (SIMR) in Kansas City in 1994. Repeated efforts to ban early stem cell research in the state of Missouri motivated the Stowers to create and endow with their personal funds a new entity, the Stowers Medical Institute (SMI), in 2005 to fund early stem cell research outside of the state. The Stowers' funding of SMI is in addition to the $2 billion combined endowments they have created for SIMR.

Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of nearly $500 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, transplantation biology and photomedicine. MGH and Brigham and Women's Hospital are founding members of Partners HealthCare HealthCare System, a Boston-based integrated health care delivery system.

Media Contact: Sue McGreevey, MGH Public Affairs

Physician Referral Service: 1-800-388-4644
Information about Clinical Trials